Navigation Links
Drugs like aspirin could reduce breast cancer and help existing sufferers
Date:3/6/2008

Anti-inflammatory drugs like aspirin may reduce breast cancer by up to 20 per cent, according to an extensive review carried out by experts at Londons Guys Hospital and published in the March issue of IJCP, the International Journal of Clinical Practice.

But they stress that further research is needed to determine the best type, dose and duration and whether the benefits of regularly using non-steroidal anti-inflammatory drugs (NSAIDs) outweigh the side effects, especially for high-risk groups.

Our review of research published over the last 27 years suggests that, in addition to possible prevention, there may also be a role for NSAIDs in the treatment of women with established breast cancer says Professor Ian Fentiman from the Hedley Atkins Breast Unit at the hospital, part of Guy's and St Thomas' NHS Foundation Trust.

NSAID use could be combined with hormone therapy or used to relieve symptoms in the commonest cause of cancer-related deaths in women.

Professor Fentiman and Mr Avi Agrawal reviewed 21 studies covering more than 37,000 women published between 1980 and 2007.

Their review included 11 studies of women with breast cancer and ten studies that compared women who did and did not have the disease.

The purpose of a review like this is to look at a wide range of published studies and see if it is possible to pull together all the findings and come to any overarching conclusions explains Professor Fentiman. This includes looking at any conflicting results and exploring how the studies were carried out.

For example some of the studies we looked at as part of this review found no links between NSAIDs and reduced levels of breast cancer, while others suggested that taking NSAIDs can reduce the breast cancer risk by about a fifth.

Having weighed up the findings from over 20 studies, we have concluded that NSAIDs may well offer significant protection against developing breast cancer in the first place and may provide a useful addition to the treatment currently available to women who already have the disease.

Recent studies of NSAIDs use have shown about a 20 per cent risk reduction in the incidence of breast cancer, but this benefit may be confined to aspirin use alone and not other NSAIDs.

Previous studies have suggested that NSAIDs like aspirin and ibuprofen, which have traditionally been used as mainstream non-prescription analgesics, may provide protection against coronary heart disease and some malignancies, such as colorectal cancer.

But Professor Fentiman is urging caution until further research fully weighs up the pros and cons of using NSAIDs to prevent and treat breast cancer.

Our review did not look at the potential side effects of using NSAIDs on a regular basis stresses Professor Fentiman These can include gastrointestinal bleeding and perforation which can carry a significant risk of ill health and death.

It would be essential to take these negative effects into account before we could justify routinely using NSAIDs like aspirin to prevent breast cancer.

More research is clearly needed and we are not advocating that women take these non prescription drugs routinely until the benefits and risks are clearer.

But our findings clearly indicate that these popular over-the-counter drugs could, if used correctly, play an important role in preventing and treating breast cancer.


'/>"/>

Contact: Annette Whibley
wizard.media@virgin.net
Blackwell Publishing Ltd.
Source:Eurekalert

Related medicine news :

1. New Mini-Documentary Exposes Psychiatric Drugs Turning Kids into Killers
2. Although Remicade and Humira Are Being Increasingly Prescribed for Crohns Disease and Ulcerative Colitis, Insurers Are Subjecting Both Drugs to Multiple Cost-Control Strategies
3. China Nepstar Chain Drugstore to Implement SAP ERP Solution to Optimize Management and Cost Controls and Enhance Operating Efficiencies
4. Nanomedicine system engineered to enhance therapeutic effects of injectable drugs
5. ADHD Drugs Wont Raise Risk of Substance Abuse
6. Zebrafish provide useful screening tool for genes, drugs that protect against hearing loss
7. Gene expression differences between Europeans and Africans affect response to drugs, infections
8. Two Drugs Found Equal in Treatment of Septic Shock
9. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
10. Drugs used for cancer-associated anemia linked with increased risk of blood clots, death
11. Anemia Drugs for Cancer Patients Increase Death Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... It can be argued that people these days ... members as they do for their human friends and family. As pets have ... highest quality and most innovative pet products has also increased. , For ...
(Date:12/6/2016)... IN (PRWEB) , ... December 06, 2016 , ... ... benefits advisory organization, is proud to announce it has added CXC Solutions (CXC) ... benefits management solutions. These solutions are tailored to help benefits advisors reduce ...
(Date:12/6/2016)... ... 2016 , ... METTLER TOLEDO has launched its online ... papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, brochures, datasheets, user manuals, ... webinars and videos available online, visit the METTLER TOLEDO Expertise Library . ...
(Date:12/6/2016)... , ... December 06, 2016 , ... ... fascinating recount of a powerful woman's story of sacrifice and enlightenment. ... of published author, Carolyn Fryer. Always looking for creative outlets, Carolyn gravitated toward ...
(Date:12/6/2016)... ... December 06, 2016 , ... U.S. Security Associates (USA) was ... for their industry leading training methods that engage their associates and link their ... global elite in employer-sponsored training and development programs. , “The 2017 Training Top ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... LONDON , Dec. 5, 2016 Spain ... GlobalData,s new report, "Spain Glaucoma Surgery Devices Market ... Spain Glaucoma Surgery Devices market. The report provides value, ... average prices (USD) within market segements - Canaloplasty Micro ... provides company shares and distribution shares data for each ...
(Date:12/5/2016)... , Dec. 5, 2016  Cornerstone Pharmaceuticals, Inc., ... presented data from two Phase I trials evaluating ... the 58th annual meeting of the American Society ... California . The two datasets show encouraging ... myeloid leukemia (AML) and T-cell non-Hodgkin,s lymphoma (T-cell ...
(Date:12/5/2016)... 2016  Pennsylvania Physician General Dr. Rachel Levine ... Gary Tennis today filled prescriptions for naloxone, a ... York to demonstrate how anyone ... as a prescription to acquire naloxone at any pharmacy ... remember that any Pennsylvanian can walk up to their ...
Breaking Medicine Technology: